Resources
BNET Business Dictionary
- Advertisement
- a public announcement by a company in a newspaper, on television or radio, or over the Internet, intended to attract buyers for a product or service
- Advertisement definition on BNET »
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Biogen Idec and Neurimmune Therapeutics Announce Alliance to Develop Treatments for Alzheimer's Disease
- CAMBRIDGE, Mass. & ZURICH, Switzerland -- Biogen Idec (NASDAQ: BIIB) and Neurimmune Therapeutics AG today announced they have entered into an agreement for the worldwide development and commercialization of novel, fully human antibodies for the treatment of Alzheimer's disease AD. The alliance will focus on the development of antibodies that...
- Research articles 2007-11-20
- Statins May Slow the Effects of Alzheimer's Disease According to New Study; Nymox (NASDAQ: NYMX) Has Global Patent Rights for Statin Drugs for the Treatment and Prevention of Alzheimer's Disease.
- HASBROUCK HEIGHTS, N.J., Nov 18, 2005 CCNMatthews via COMTEX -- Cholesterol-lowering drugs like statins were found to slow the progression of Alzheimer's disease AD in a new three year study of 342 AD patients (J. Neurol. Neurosurg. Psychiatry De HASBROUCK HEIGHTS, N.J., Nov 18, 2005 (CCNMatthews...
- Research articles 2005-11-18
- Statin Drug Potential for Alzheimer's Disease Bolstered by Recent Studies; Nymox (NASDAQ: NYMX) Has Global Patent Rights for Statin Drugs for the Treatment and Prevention of Alzheimer's Disease.
- HASBROUCK HEIGHTS, N.J., Feb 10, 2006 CCNMatthews via COMTEX -- The potential for statin drugs to treat or reduce the risk of Alzheimer's disease AD has been bolstered by several recently published studies and reviews in leading medical and scien HASBROUCK HEIGHTS, N.J., Feb 10, 2006...
- Research articles 2006-02-10
- Applied NeuroSolutions Founding Scientist, Dr. Peter Davies, Featured in New York Times Article on Alzheimer's Disease
- VERNON HILLS, Ill. -- Applied NeuroSolutions, Inc. (OTC BB:APNS)(www.appliedneurosolutions.com) a Company focused on the development of an integrated product portfolio for the treatment and diagnosis of Alzheimer's disease AD, today announced it's long-standing founding scientist, Dr. Peter Davies, a world renowned expert on AD research, was interviewed in a feature...
- Research articles 2007-06-11
- Resverlogix Collaborates NexVas(TM) AD Program with Leading Alzheimer's Researcher at Sun Health Research Institute; Dr. Larry Sparks first to identify the link between cholesterol and Alzheimer's disease.(Clinical report)
- CALGARY, ALBERTA, Jun 19, 2007 CCNMatthews via COMTEX -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce today that it has signed a collaborative research agreement with Dr. Larry Sparks of the Sun Health Research Insti CALGARY, ALBERTA, Jun 19, 2007 CCNMatthews via COMTEX -- ...
- Research articles 2007-06-19
- << Previous
- page 1 of 1
- Next >>
